Assessing adherence and persistence to non-vitamin K antagonist oral anticoagulants (NOACs) among patients with atrial fibrillation in tertiary-care referral centers in Malaysia

• Главные авторы: Mohammed A Kubas (Автор), Fatiha Hana Shabaruddin (Автор), Wardati Mazlan-Kepli (Автор), Nirmala Jagan (Автор), Sahimi Mohamed (Автор), Nor Ilyani Mohamed Nazar (Автор), Che Suraya Zin (Автор)
• Формат: ‌
• Опубликовано: Wolters Kluwer Medknow Publications, 2020-01-01T00:00:00Z.
• Предметы: article
• Online-ссылка: Connect to this object online.

Introduction: Non-vitamin K antagonist oral anticoagulants (NOACs), such as dabigatran and rivaroxaban, are now available for stroke prevention in patients with atrial fibrillation (AF) and are often clinically preferred over vitamin K antagonists (VKAs), such as warfarin. Data describing adherence...